Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Dejnirattisai W., Shaw RH., Supasa P., Liu C., Stuart AS., Pollard AJ., Liu X., Lambe T., Crook D., Stuart DI., Mongkolsapaya J., Nguyen-Van-Tam JS., Snape MD., Screaton GR., Com-COV2 study group .